# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-25-021304
Filing Date
2025-05-01
Accepted
2025-05-01 06:25:29
Documents
48
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | xfor-20250501.htm iXBRL | 8-K | 33317
2 | EX-99.1 | a991earningsreleasedatedma.htm | EX-99.1 | 97302
3 | EX-99.2 | ex_992xx4updatedinvestor.htm | EX-99.2 | 37613
7 |  | ex_992xx4updatedinvestor001.jpg | GRAPHIC | 86428
8 |  | ex_992xx4updatedinvestor002.jpg | GRAPHIC | 292598
9 |  | ex_992xx4updatedinvestor003.jpg | GRAPHIC | 138334
10 |  | ex_992xx4updatedinvestor004.jpg | GRAPHIC | 124384
11 |  | ex_992xx4updatedinvestor005.jpg | GRAPHIC | 128174
12 |  | ex_992xx4updatedinvestor006.jpg | GRAPHIC | 83249
13 |  | ex_992xx4updatedinvestor007.jpg | GRAPHIC | 54340
14 |  | ex_992xx4updatedinvestor008.jpg | GRAPHIC | 128618
15 |  | ex_992xx4updatedinvestor009.jpg | GRAPHIC | 92729
16 |  | ex_992xx4updatedinvestor010.jpg | GRAPHIC | 95564
17 |  | ex_992xx4updatedinvestor011.jpg | GRAPHIC | 91275
18 |  | ex_992xx4updatedinvestor012.jpg | GRAPHIC | 103669
19 |  | ex_992xx4updatedinvestor013.jpg | GRAPHIC | 105741
20 |  | ex_992xx4updatedinvestor014.jpg | GRAPHIC | 67105
21 |  | ex_992xx4updatedinvestor015.jpg | GRAPHIC | 137721
22 |  | ex_992xx4updatedinvestor016.jpg | GRAPHIC | 137726
23 |  | ex_992xx4updatedinvestor017.jpg | GRAPHIC | 111607
24 |  | ex_992xx4updatedinvestor018.jpg | GRAPHIC | 102531
25 |  | ex_992xx4updatedinvestor019.jpg | GRAPHIC | 98652
26 |  | ex_992xx4updatedinvestor020.jpg | GRAPHIC | 130888
27 |  | ex_992xx4updatedinvestor021.jpg | GRAPHIC | 107494
28 |  | ex_992xx4updatedinvestor022.jpg | GRAPHIC | 127144
29 |  | ex_992xx4updatedinvestor023.jpg | GRAPHIC | 95759
30 |  | ex_992xx4updatedinvestor024.jpg | GRAPHIC | 120420
31 |  | ex_992xx4updatedinvestor025.jpg | GRAPHIC | 113341
32 |  | ex_992xx4updatedinvestor026.jpg | GRAPHIC | 96877
33 |  | ex_992xx4updatedinvestor027.jpg | GRAPHIC | 135353
34 |  | ex_992xx4updatedinvestor028.jpg | GRAPHIC | 28949
35 |  | ex_992xx4updatedinvestor029.jpg | GRAPHIC | 127410
36 |  | ex_992xx4updatedinvestor030.jpg | GRAPHIC | 115952
37 |  | ex_992xx4updatedinvestor031.jpg | GRAPHIC | 103698
38 |  | ex_992xx4updatedinvestor032.jpg | GRAPHIC | 80931
39 |  | x4logoa.jpg | GRAPHIC | 4345
| Complete submission text file | 0001628280-25-021304.txt |  | 5247339

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | xfor-20250501.xsd | EX-101.SCH | 1785
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | xfor-20250501_lab.xml | EX-101.LAB | 23449
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | xfor-20250501_pre.xml | EX-101.PRE | 13583
50 | EXTRACTED XBRL INSTANCE DOCUMENT | xfor-20250501_htm.xml | XML | 2824

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 25899188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)